These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8618249)

  • 1. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
    Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
    J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions.
    Scharman EJ
    J Toxicol Clin Toxicol; 1998; 36(1-2):19-25. PubMed ID: 9541036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron for treating nausea and vomiting in the poisoned patient.
    Reed MD; Marx CM
    Ann Pharmacother; 1994 Mar; 28(3):331-3. PubMed ID: 8193420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Polati E; Verlato G; Finco G; Mosaner W; Grosso S; Gottin L; Pinaroli AM; Ischia S
    Anesth Analg; 1997 Aug; 85(2):395-9. PubMed ID: 9249120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.
    Culver MA; Richards EC; Jarrell DH; Edwards CJ
    J Emerg Med; 2017 Nov; 53(5):629-634. PubMed ID: 28987314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.
    Larijani GE; Gratz I; Afshar M; Minassian S
    Anesth Analg; 1991 Sep; 73(3):246-9. PubMed ID: 1831015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.
    Tan J; Wang S; Liang X; Li CC; Zhang J; Zhao Z; Kong XR; Deng X; Peng L; Yang C
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28941006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding.
    McKenzie R; Uy NT; Riley TJ; Hamilton DL
    Anesth Analg; 1996 Dec; 83(6):1218-22. PubMed ID: 8942589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
    Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
    J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
    Holdsworth MT; Raisch DW; Winter SS; Chavez CM
    Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP).
    Thanacoody HK; Gray A; Dear JW; Coyle J; Sandilands EA; Webb DJ; Lewis S; Eddleston M; Thomas SH; Bateman DN
    BMC Pharmacol Toxicol; 2013 Apr; 14():20. PubMed ID: 23556549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
    J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.